Home / Companies / MedImmune LLC / Page 5

MedImmune LLC Company Information

Employees at MedImmune LLC

Showing 14 of 6060

JOB TITLE	WORK EMAIL	WORK PHONE	LOCATION
Principal Investigator			Washington, District Of Columbia
Vice President			Washington, District Of Columbia
Employee			Washington, District Of Columbia
Directivo			Gaithersburg, Maryland
Director, Legal Affairs			Washington
Vice President, Vaccine Research			Seattle, Washington
Director, Biostatistics			San Francisco, California
Vice President, Regulatory Operations and Compliance			Lake Bluff, Illinois
Employee			Washington, District Of Columbia
Scientist I			Philadelphia, Pennsylvania
Vice President and Therapeutic Area Head, Inflammation and Autoimmunity			Baltimore, Maryland
Vice President, Research and Development-Translational Sciences			Damascus, Maryland
Senior Director Of Corporate Communications			District Of Columbia
Vice President, Global Business Planning and Operations			Maryland

Principal Investigator

Washington, District Of Columbia

Vice President

Washington, District Of Columbia

Employee

Washington, District Of Columbia

Directivo

Gaithersburg, Maryland

Director, Legal Affairs

Washington

Vice President, Vaccine Research

Seattle, Washington

Director, Biostatistics

San Francisco, California

Vice President, Regulatory Operations and Compliance

Lake Bluff, Illinois

Employee

Washington, District Of Columbia

Scientist I

Philadelphia, Pennsylvania

Vice President and Therapeutic Area Head, Inflammation and Autoimmunity

Baltimore, Maryland

Vice President, Research and Development-Translational Sciences

Damascus, Maryland

Senior Director Of Corporate Communications

District Of Columbia

Vice President, Global Business Planning and Operations

Maryland

Load more results

Enter an employee name to search and verify work emails, phone numbers and social links etc.

MedImmune LLC's Email Format

We found 6 email formats used by MedImmune LLC employees. The most common MedImmune LLC email format is last first_initial ex.(doej@medimmune.com) being used 69% of the time.